Biogen (BIIB) Assets (2009 - 2026)
Biogen (BIIB) posted quarterly Assets of $32.1 billion for Q2 2026, up 13.26% year-over-year from $28.3 billion in Q2 2025, and up 8.83% quarter-over-quarter from $29.5 billion in Q1 2026.
Biogen (BIIB) Assets (2009 - 2026) Analysis & Trends
Biogen's Assets history runs 18 years deep, the most recent figure standing at $32.1 billion for Q2 2026.
- In Q2 2026, Assets rose 13.26% year-over-year to $32.1 billion; the TTM figure through Jun 2026 stood at $32.1 billion (up 13.26% YoY), while the FY2025 annual figure was $29.4 billion, up 4.96% from the prior year.
- Assets for Q2 2026 stood at $32.1 billion, up from $29.5 billion in the prior quarter.
- The five-year high for Assets was $32.1 billion in Q2 2026, with the low at $23.6 billion in Q1 2022.
- The 5-year median for Assets is $27.4 billion (2023), against an average of $27.2 billion.
- The sharpest annual moves came in 2022 and 2023: Assets fell 1.01% in 2022, then gained 13.43% in 2023.
- Biogen's Assets stood at $24.6 billion in 2022, then advanced by 9.33% to $26.8 billion in 2023, then increased by 4.49% to $28.0 billion in 2024, then increased by 4.96% to $29.4 billion in 2025, then increased by 8.99% to $32.1 billion in 2026.
- Business Quant data shows BIIB's Assets at $32.1 billion in Q2 2026, $29.5 billion in Q1 2026, and $29.4 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 82.83 Bn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn | 32.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.09 Bn |
| Mar 31, 2026 | 29.48 Bn |
| Dec 31, 2025 | 29.44 Bn |
| Sep 30, 2025 | 29.21 Bn |
| Jun 30, 2025 | 28.33 Bn |
| Mar 31, 2025 | 28.03 Bn |
| Dec 31, 2024 | 28.05 Bn |
| Sep 30, 2024 | 28.31 Bn |
| Jun 30, 2024 | 26.80 Bn |
| Mar 31, 2024 | 26.57 Bn |
| Dec 31, 2023 | 26.84 Bn |
| Sep 30, 2023 | 28.19 Bn |
| Jun 30, 2023 | 25.16 Bn |
| Mar 31, 2023 | 24.60 Bn |
| Dec 31, 2022 | 24.55 Bn |
| Sep 30, 2022 | 24.85 Bn |
| Jun 30, 2022 | 25.08 Bn |
| Mar 31, 2022 | 23.61 Bn |
| Dec 31, 2021 | 23.88 Bn |
| Sep 30, 2021 | 23.81 Bn |